CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

134 hedge funds and large institutions have $315M invested in CytomX Therapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 15 closing their positions.

Holders
134
Holders Change
+17
Holders Change %
+14.53%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
47
Reduced
38
Closed
15
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
-$5K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$12.1M
2
State Street
2
State Street
Massachusetts
$18.3M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$8.61M
4
RI
4
RTW Investments
New York
$12.6M
5
HIM
5
Hillsdale Investment Management
Ontario, Canada
$3.11M

Top Sellers

1
Victory Capital Management
1
Victory Capital Management
Texas
$19M
2
BI
2
BVF Inc
California
$26M
3
MB
3
MPM BioImpact
Massachusetts
$0
4
CS
4
Candriam SCA
Luxembourg
$0
5
PA
5
Perceptive Advisors
New York
$21.5M
Name Market Value Shares Shares
Change 		Shares
Change %
IA
151
IFP Advisors
Florida
– – – –
Group One Trading
152
Group One Trading
Illinois
– – – –
3 4 5 6
7